Tenaya Therapeutics (TNYA) Change in Account Payables (2020 - 2026)
Tenaya Therapeutics' quarterly Change in Account Payables came in at -$1.5 million in Q1 2026, down 285.22% year-on-year from $788233.6 in Q1 2025, and down 374.95% quarter-over-quarter from $531000.0 in Q4 2025.
Tenaya Therapeutics has reported Change in Account Payables for 7 years, with the latest figure at -$1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 285.22% year-over-year to -$1.5 million; the trailing twelve-month figure through Mar 2026 stood at -$2.5 million (down 12.5% YoY), and the FY2025 full-year result was -$1.4 million, down 146.13% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$1.5 million, down from $531000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $3.5 million in Q4 2022, with the low at -$2.8 million in Q3 2023.
- Average Change in Account Payables over 5 years is -$299588.2, with a median of -$379000.0 recorded in 2025.
- Peak annual rise in Change in Account Payables reached 422.87% in 2023, while the deepest fall reached 968.77% in 2023.
- Tracing TNYA's Change in Account Payables over 5 years: stood at $3.5 million in 2022, then sank by 108.81% to -$305000.0 in 2023, then sank by 129.84% to -$701000.0 in 2024, then surged by 175.75% to $531000.0 in 2025, then tumbled by 374.95% to -$1.5 million in 2026.
- The last three Change in Account Payables figures came in at -$1.5 million (Q1 2026), $531000.0 (Q4 2025), and -$447000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Tenaya Therapeutics | 193.57 Mn | 193.57 Mn | - | -1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | 531,000.00 |
| Dec 31, 2025 | 531,000.00 |
| Sep 30, 2025 | -447,000.00 |
| Sep 30, 2025 | -447,000.00 |
| Jun 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Mar 31, 2025 | -379,000.00 |
| Mar 31, 2025 | -379,000.00 |
| Dec 31, 2024 | -701,000.00 |
| Dec 31, 2024 | -701,000.00 |
| Sep 30, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | -305,000.00 |
| Dec 31, 2023 | -305,000.00 |
| Sep 30, 2023 | -2.75 Mn |
| Sep 30, 2023 | -2.75 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | -1.32 Mn |
| Mar 31, 2023 | -1.32 Mn |
| Dec 31, 2022 | 3.46 Mn |
| Dec 31, 2022 | 3.46 Mn |
| Sep 30, 2022 | 317,000.00 |
| Sep 30, 2022 | 317,000.00 |
| Jun 30, 2022 | -341,000.00 |
| Jun 30, 2022 | -341,000.00 |
| Mar 31, 2022 | -1.78 Mn |
| Mar 31, 2022 | -1.78 Mn |
| Dec 31, 2021 | 6.08 Mn |
| Dec 31, 2021 | 6.08 Mn |
| Sep 30, 2021 | 1.16 Mn |
| Sep 30, 2021 | 1.16 Mn |
| Jun 30, 2021 | 745,000.00 |
| Jun 30, 2021 | 745,000.00 |
| Mar 31, 2021 | 618,000.00 |
| Mar 31, 2021 | 618,000.00 |
| Dec 31, 2020 | -385,000.00 |
| Dec 31, 2020 | -385,000.00 |
| Sep 30, 2020 | 105,000.00 |
| Sep 30, 2020 | 105,000.00 |